Published in
Taylor and Francis Group, Leukemia & Lymphoma, 7(58), p. 1607-1616, 2016
DOI: 10.1080/10428194.2016.1256481
Links
Tools
Brentuximab vedotin activity in diffuse large B-cell lymphoma with CD30 undetectable by visual assessment of conventional immunohistochemistry
Journal article published in 2016 by
Nancy L. Bartlett 
,
Mitchell R. Smith ,
Bartlett Nl,
Tanya Siddiqi,
Smith Mr,
Ranjana H. Advani,
Advani Rh,
Owen A. O’Connor,
Jeff P. Sharman,
O'Connor Oa,
Tatyana Feldman,
Sharman Jp,
Kerry J. Savage,
Andrei R. Shustov,
Savage Kj
and other authors.
,
Mitchell R. Smith ,
Bartlett Nl,
Tanya Siddiqi,
Smith Mr,
Ranjana H. Advani,
Advani Rh,
Owen A. O’Connor,
Jeff P. Sharman,
O'Connor Oa,
Tatyana Feldman,
Sharman Jp,
Kerry J. Savage,
Andrei R. Shustov,
Savage Kj
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 